Effect of Adding Aripiprazole to Li Therapy in Children & Adolescents with BPD
Not Applicable
- Conditions
- Bipolar Disorder Manic/Mixed phase in Children & Adolescents.Manic episode
- Registration Number
- IRCT201108027202N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
hospitalized Patients, between 10 to 17 years old, diagnosis of BPD based on DSM-IV-TR
Exclusion criteria: Hypersensitivity to Aripiprazole or Lithium, Severe Medical Conditions (cardiovascular disorders, hepatic, renal and thyroid dysfunctions & severe diabetes), Serious Neurological Disorders, Dehydration, Ketoacidosis, Pregnancy, Lactation, MR patients
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy. Timepoint: Baseline, 3 and 6 weeks after the treatment. Method of measurement: Young Mania Rating Scale, CGI-Improvement and CGAS Scales.
- Secondary Outcome Measures
Name Time Method